Skip to main content
EMulate Therapeutics, Inc. (EMTX)
EMulate Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
2,300,000
Deal Size
$11.50M

EMulate Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Net Income
-22.093.46
Depreciation & Amortization
1.040.59
Share-Based Compensation
6.043.6
Other Operating Activities
11.69-10.83
Operating Cash Flow
-3.32-4.02
Share Issuance / Repurchase
1.640
Debt Issued / Paid
1.912.76
Financing Cash Flow
3.552.77
Net Cash Flow
0.23-1.25
Free Cash Flow
-3.32-4.02
Free Cash Flow Margin
-1378.42%-3555.75%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).